Screening for Psychological Distress in Adult Primary Brain Tumor Patients and Caregivers: Considerations for Cancer Care Coordination
Overview
Authors
Affiliations
Introduction: This study aimed to assess psychological distress (PD) as scored by the Distress Thermometer (DT) in adult primary brain tumor patients and caregivers (CGs) in a clinic setting and ascertain if any high-risk subgroups for PD exist.
Material And Methods: From May 2012 to August 2013, n = 96 patients and n = 32 CG underwent DT screening at diagnosis, and a differing cohort of n = 12 patients and n = 14 CGs at first recurrence. Groups were described by diagnosis (high grade, low grade, and benign) and English versus non English speaking. Those with DT score ≥4 met caseness criteria for referral to psycho-oncology services. One-way ANOVA tests were conducted to test for between-group differences where appropriate.
Results: At diagnosis and first recurrence, 37.5 and 75.0% (respectively) of patients had DT scores above the cutoff for distress. At diagnosis, 78.1% of CGs met caseness criteria for distress. All CGs at recurrence met distress criterion. Patients with high-grade glioma had significantly higher scores than those with a benign tumor. For patients at diagnosis, non English speaking participants did not report significantly higher DT scores than English speaking participants.
Discussion: Psychological distress is particularly elevated in CGs and in patients with high-grade glioma at diagnosis. Effective PD screening, triage, and referral by skilled care coordinators are vital to enable timely needs assessment, psychological support, and effective intervention.
Siddi F, Emedom-Nnamdi P, Catalino M, Rana A, Boaro A, Dawood H Cancers (Basel). 2025; 17(1.
PMID: 39796767 PMC: 11719951. DOI: 10.3390/cancers17010139.
Chen J, Shaw J, Dhillon H, Halkett G, McDougall E, Nowak A J Patient Rep Outcomes. 2025; 9(1):6.
PMID: 39792320 PMC: 11723857. DOI: 10.1186/s41687-024-00835-4.
Staub-Bartelt F, Obermayr S, Sabel M, Rapp M Front Oncol. 2024; 14:1457017.
PMID: 39650064 PMC: 11621086. DOI: 10.3389/fonc.2024.1457017.
Griffin C, Carlson M, Walker M, Lynam J, Paul C Neurooncol Pract. 2024; 11(6):813-820.
PMID: 39554794 PMC: 11567741. DOI: 10.1093/nop/npae049.
Staub-Bartelt F, Steinmann J, Wienand M, Sabel M, Rapp M Diseases. 2024; 12(9).
PMID: 39329886 PMC: 11431417. DOI: 10.3390/diseases12090217.